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The demand for real-time monitoring of cell functions and cell conditions has dramatically increased with the 
emergence of Organ-On-a-Chip (OOC) systems. However, the incorporation of co-cultures and microfluidic 
channels in OOC systems increases their biological complexity and therefore makes the analysis and monitoring 
of analytical parameters inside the device more difficult. In this work, we present an approach to integrate 
multiple sensors in an extremely thin, porous and delicate membrane inside a Liver-On-a-Chip device. Specifically, 
three electrochemical dissolved oxygen (DO) sensors were inkjet-printed along the microfluidic channel allowing 
local online monitoring of oxygen concentrations. This approach demonstrates the existence of an oxygen 
gradient up to 17.5% for rat hepatocytes and 32.5% for human hepatocytes along the bottom channel. Such 
gradients are considered crucial for the appearance of zonation of the liver. Inkjet printing (IJP) was the selected 
technology as it allows drop on demand material deposition compatible with delicate substrates, as used in this 
study, which cannot withstand temperatures higher than 130 °C. For the deposition of uniform gold and silver 
conductive inks on the porous membrane, a primer layer using SU-8 dielectric material was used to seal the 
porosity of the membrane at defined areas, with the aim of building a uniform sensor device. As a proof-of-
concept, experiments with cell cultures of primary human and rat hepatocytes were performed, and oxygen 
consumption rate was stimulated with carbonyl-cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), 
accelerating the basal respiration of 0.23 ± 0.07 nmol/s/106 cells up to 5.95 ± 0.67 nmol/s/106cells s for rat cells and 
the basal respiration of 0.17 ± 0.10 nmol/s/106 cells by up to 10.62 ± 1.15 nmol/s/106cells for human cells, with 
higher oxygen consumption of the cells seeded at the outflow zone. These results demonstrate that the approach 
of printing sensors inside an OOC has tremendous potential because IJP is a feasible technique for the integration 
of different sensors for evaluating metabolic activity of cells, and overcomes one of the major challenges still 
remaining on how to tap the full potential of OOC systems. 
Introduction 
Over the past two decades, multidisciplinary efforts in cell 
biology and bioengineering have led to highly functional in-
vitro cell culture platforms enabling the depiction of micro-
environmental signals.1 The purpose of in-vitro culture 
platforms is to model reality with the highest possible 
attention to detail in order to mimic human and other animal 
pathophysiology. As a result, cell biology systems are moving 
from conventional in-vitro models2 to more complex systems, 
which are better able to capture the critical features of cellular 
microenvironments.3 In this context, the concept of ‘Organ-
On-a-Chip’ (OOC) has emerged.4–6 Micro-engineering 
strategies, such as microfabrication and microfluidic 
technologies provide a number of unique advantages and 
benefits in the study of organ biology.7 An OOC system 
consists of a microfluidic cell culture device that contains 
continuously perfused chambers inhabited by living cells 
arranged to simulate tissue- and organ-level physiology.8,9 The 
main advantage of these miniaturized organ models over 
conventional models2 is that they can more accurately predict 
human responses because they are able to capture the 
structural, mechanical, chemical, and communicative 
complexities on in-vivo systems.3 For this reason, in some areas 
of cell biology, OOC systems could be an effective alternative 
to animal testing as the process of testing drugs with animals 
often fails to predict human pathophysiology.10,11  
The ability to monitor cell culture conditions and their 
response to drugs or other stimulations allows continuous 
improvement of the models. Currently, analysis of OOC cell 
cultures mainly relies on conventional tools such as optical 
measurement techniques using time-lapse bright field and 
fluorescence microscopy12 in combination with various 
staining techniques as well as collection of supernatants and 
cellular samples.13 However, these traditional techniques are 
problematic because they are time-consuming, require manual 
sample collection from the microfluidic system, need large 
working volumes, and are subject to system disturbance, 
making them unsuitable for miniaturized cell culture systems. 
Consequently, over the past few decades, a great deal of 
research has been carried out in the development of sensors 
for cell biology applications and of particular interest has been 
the development of miniaturized sensors with improved 
sensitivities and limits of detection.14,15 
Recently, a number of review articles have advocated the 
integration of functional tools for cell monitoring within OOC 
systems16–21 which has led to a strong demand for the 
integration of online sensor capabilities. Some studies have 
incorporated high-cost commercial microsensors;22 however, 
only few research works have described the integration of 
minimal invasive sensors in OOC devices. This can be easily 
understood because conventional manufacturing processes do 
not allow for the direct integration of sensors in OOC systems, 
due to complex,22,23 multi-step fabrication processes, high 
temperature requirements or material incompatibility, which 
increase the complexity of the whole system and the overall 
probability of failure.24 However, in the last few years, various 
strategies have been proposed for real-time monitoring 
without compromising the operation of the OOC. Some works 
have focussed on the monitoring of the physical parameters 
external to the cell culture area of the OOC, using modular 
sensing platforms23,25–27 in-line with the microfluidic system to 
measure the inlets and outlets without disturbing the cell 
culture area. Recently, Zhang et al.23 presented a fully 
integrated multi-sensing platform to achieve automated in-situ 
monitoring of biophysical (pH, oxygen, temperature) and 
biochemical parameters of a liver- and heart-on-a-chip model 
systems. Other strategies have gone a step further by placing a 
monitoring device inside the OOC. In this regard, some studies 
have incorporated external probes modifying the bioreactor 
design,22,28,29 others have integrated sensors inside the cell 
culture area, in the top and or bottom covers of the device 
without disturbing its functionality.30 Curto et al.31 presented 
the coupling of organic electrochemical transistors with 
microfluidics to achieve multi-parametric (optical imaging, 
impedance monitoring, and metabolite sensing) monitoring of 
live kidney cells. These sensing elements were placed at the 
glass bottom cover of the system using conventional 
microtechnology techniques, in clean room environments 
using a complex, multi-step lithography process. Henry et al.32 
reported embedded electrodes for trans-epithelial electrical 
resistance (TEER) measurements, patterned onto the 
polycarbonate substrate forming the top and bottom covers 
on an OOC system. The same system has been reported with 
the integration of both TEER and multi-electrode arrays 
sensors.33 More recently, Lind et al.34 presented a new 
approach to integrate strain gauge sensors inside a cell 
incubator environment, fully based on three-dimensional 
printing techniques for a continuous electronic readout of 
contractile stress of cardiac micro-tissues. 
Among all the necessary parameters to be monitored 
inside an OOC system, the amount of oxygen is one of the 
most important. Oxygen is an important regulatory parameter, 
influencing cell differentiation and function.19 In addition, 
cellular function and behaviour are affected by oxygen tension 
in micro-enviroments.20 For this reason, changes in oxygen 
tension, either above physiological oxygen tension (hyperoxia) 
or below physiological levels (hypoxia) or even a complete 
absence of oxygen (anoxia), can trigger potent biological 
responses and therefore need to be controlled precisely. With 
improvements in the microfabrication technology field, the 
miniaturization of oxygen sensors has dramatically increased. 
This advance has allowed an easier integration of oxygen 
sensors principally of microfluidic systems for in-situ 
measurements.20,35 Some researchers have designed their own 
oxygen sensors incorporating them in bioreactors;25,36,37 
others, have modified the system in order to incorporate 
commercial oxygen probes.22,29,38 However, the incorporation 
of co-cultures and several microfluidic channels separated by 
membranes inside OOC systems has made them more complex 
and hindered the integration of sensors. The challenge 
therefore is how to integrate sensors inside their own channels 
and embed them in the cell culture membrane without 
damaging its filtering function. 
In this research study, we present for the first time, to the 
best of our knowledge, the integration of amperometric 
oxygen sensors in an ultrathin and porous cell culture 
membrane of a Liver-On-a-Chip system to achieve in-situ, 
simultaneous and real-time monitoring of oxygen along the 
cell culture microfluidic chamber. Oxygen availability is 
particularly important in the field of liver pathophysiology, 
because the oxygen gradient is considered crucial for the 
appearance of zonation of metabolism in the liver 
microarchitecture.39 Zonation is critical for achieving accurate 
models of in-vivo function, and because several 
transformations occur in the different sinusoidal zones 
affecting hepatotoxicity, the monitoring of oxygen is crucial. To 
overcome this technological challenge, we fabricated oxygen 
sensors by Inkjet Printing (IJP). IJP is a promising, low-cost 
printing technique alternative to conventional microelectronic 
fabrication, which allows the integration of electrodes in a 
wide range of substrates compatible with low temperature 
processes. IJP technology has recently been used to integrate 
electrodes in cell culture devices,40 microfluidic systems41 and 
even for the development of parts of microfluidic channels.42 
In IJP, droplets of liquids are ejected from a small nozzle. There 
is no direct contact between the print head and the substrate. 
In addition, no mask is required for the process, since the 
droplets are transferred directly to the substrate. This direct 
writing approach without the need of masks drastically 
reduces overall fabrication time and the cost of the sensors, 
and facilitates iterative design changes during sensor 
development. 
In this work, three electrochemical dissolved oxygen (DO) 
sensors were situated in the porous membrane of a specific 
Liver-On-a-Chip device, named ExoLiver,43 which mimics the 
liver sinusoid. The ExoLiver is a modular bioreactor consisting 
of two plates separated by a porous membrane, with an upper 
microfluidic channel and a static lower channel where 
hepatocyte cells are cultivated. Inkjet-printed sensors were 
integrated along the microfluidic channel, specifically in the 
bottom part of the membrane monitoring oxygen 
concentration changes in order to give real-time information 
about the state of the cell culture, to evaluate if an oxygen 
gradient exists along the hepatocytes cell culture and to 
enable the study of the oxygen consumption rate (OCR) of the 
cells under different conditions. The location of the electrodes 
embedded in the membrane is important as the main oxygen 
changes are observed in the immediate vicinity of the cell 
culture due to low cultivation volumes and unaltered 
functionality of the system. The incorporation of an array of 
sensors embedded in the membrane, which has not been 
reported to date, may provide more realistic measurements of 
oxygen changes for evaluating metabolic activity rather than 
general DO values, for example at external inlets or outlet 
ports. The principle of IJP fabrication approach and the 
morphological and functional characterization of the DO 
sensors on plastic substrate have already been demonstrated 
in our previous work.44 However, here the challenge is to 
integrate the sensors in a very thin (65 µm) and porous 
membrane, using the concept of a printed primer layer to 
partially seal the membrane porosity allowing the deposition 
of smooth layers on top of it. 
Biological proof of concept of these sensors was performed 
using primary human and rat hepatocytes cultured in the 
lower plate of the ExoLiver bioreactor. DO concentrations 
were monitored in real-time for several hours and changes in 
culture media were induced with Carbonyl-cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP), a mitochondrial 
oxidative phosphorylation uncoupler that disrupts ATP 
synthesis by transporting protons across cell membranes.45,46 
Because FCCP depolarizes mitochondrial membrane potential, 
it promotes an increase in hepatocyte respiration and hence in 
oxygen consumption, increasing the effect of the oxygen 
gradient in the vicinity of the hepatocyte cells from the inflow 
(periportal-like) to the outflow (perivenous-like) zones. The 
experimental results show that the proposed manufacturing 
approach involving the printing of sensors located next to the 
cells allows online oxygen measurements, offering a 
technological solution to better control cell metabolites, with 
the study of the oxygen gradient and the cells respiration rate 
along the bioreactor. This approach also bridges an existing 
gap regarding the integration of monitoring tools within 
perfused OOC systems. We clearly demonstrate the feasibility 
of readily embedding sensors in the porous membrane of an 
OOC system, which represents the first step toward a truly 
integrated OOC system. Such a devise will enable investigation 
of different biological parameters and thereby improve the 
predictive quality of the data used to inform clinical studies. 
Experimental 
Materials and equipment 
Three commercially available ink formulations were used for 
printing the DO sensors. A low-curing gold nanoparticle ink 
formulation (Au-LT-20 from Fraunhofer IKTS, Germany), a 
silver nanoparticle ink (DGP-40LT-15C from ANP, Korea) and a 
dielectric photoresist SU-8 (SU-8 2002 from MicroChem, USA). 
All the ink formulations were printed with a drop-on-demand 
Dimatix Materials Printer (DMP 2831 from Fujifilm Dimatix, 
USA). Microporous polytetrafluoroethylene (PTFE) membrane 
filters (JGWP04700 from Milipore, USA) were employed as 
substrates. The membrane was 65 µm thick and had a 0.2 µm 
pore size with 80% of porosity and had undergone a special 
chemical treatment to convert the hydrophobic PTFE into 
hydrophilic. Ethanol (LC/MS grade), sodium nitrate (KNO3), 
potassium hexacyanoferrate(III) (K3[Fe(CN)6]) and potassium 
hexacyanoferrate(II) trihydrate (K4[Fe(CN)6]) and hydrochloric 
acid (0.1 M) (all from Sigma Aldrich, Spain) were used for the 
preparation and characterization of the printed sensors. The 
electrochemical characterization of the sensors and the 
experimental procedure were performed with an 8-channel 
potentiostat 1030B Electrochemical Analyzer (CH Instruments, 
USA). A Clark-type commercial microelectrode (OX-NP, 
Unisense, Denmark) with a top diameter of 25 µm was used to 
correlate the DO printed sensor measurements with a 4-
channel amplifier microsensor multimeter (Unisense, 
Denmark).  
Scanning Electron Microscopy (SEM, Auriga-40 from Carl 
Zeiss) was performed to analyse the surface structure of the 
porous PTFE membrane and to study the morphology of each 
printed layer. 
Hepatocytes were isolated using Collagenase A (103586, 
Roche), CaCl2 (C3306, Sigma) and Hepes (H3375, Sigma) all 
dissolved in Hanks Balanced Solution salt (HBSS; H8264, 
Sigma). Dulbecco’s Modified Eagle’s Medium (DMEMF12; 
11320074, Gibco) was the selected culture media for primary 
hepatocyte supplemented with 2% Fetal Bovine Serum (FBS; 
04-001-1A, Reactiva), 1% penicillin plus 1% streptomycin (03-
331-1C, Reactiva), 2 mM L-glutamine (25030-024, Gibco), 1% 
amphotericin B (03-029-1C, Reactiva), 1 µM dexamethasone 
(D4902, Sigma), Dextran (31392, Sigma) and 1 µM insulin 
(103755, HCB). Hepatocytes were cultured on Poly methyl 
methacrylate (PMMA) plates previously treated with plasma 
(BD-10AV, Electro-technic products) and coated with 0.1 
mg·mL-1 collagen type 1 rat tail (A10483-01, GIBCO). 
For the experimental procedure, cells were washed with 
Dulbecco’s phosphate-buffered saline (DPBS; 02-023-1A, 
Reactiva). Indirect dynamic stimulation of the cell culture was 
performed through the perfusion system of the device 
connected to a peristaltic pump (HV707000-HARVARD 
peristaltic pump P70). FCCP (370-86-5, Cayman Chemical) was 
used to increase the oxygen consumption of the hepatocytes. 
 
Inkjet printing process 
A primer layer was printed on the membrane in order to 
selectively seal the porosity where the sensors were placed. 
The strategy to print a primer layer with IJP has been 
previously demonstrated for paper-based substrates.47,48 
However, in this study, we faced the challenge of applying the 
same strategy but in a 65 µm thick substrate with a porosity 
80%.  
Fig. 1a shows the manufacturing steps of the DO sensors. 
The first printing step was the primer layer using SU-8 ink (Fig. 
1a(i)) locally sealing only the area under the electrodes. Two 
SU-8 layers were printed using a wet-on-wet method with a 
spacing between drops (DS) of 15 µm at a print resolution of 
1693 dpi (dots per inch). This DS provided overlap as each drop 
spread. The SU-8 was cured by UV during 15 s to polymerize 
the layer by cross-linking. Gold elements (working electrode 
(WE) and counter electrode (CE)) were then printed also using 
a DS of 15 µm between each pixel (Fig. 1a(ii)). Platen 
temperature was set to 40 °C in order to evaporate the solvent 
during the printing process and to improve layer homogeneity. 
The next step was printing the silver elements for the 
development of the electrode structures that form the 
pseudo-reference electrode (pRE) using a DS of 30 µm (846 
dpi) (Fig. 1a(iii)). Both printed inks were then thermally dried 
at 100 °C for 5 min and then sintered on a hotplate at 130 °C 
for 40 min. The sintering temperature was selected as it is the 
maximum temperature that the PTFE membrane can 
withstand without destroying its hydrophilic treatment. With 
these sintering conditions, the sheet resistance of both 
metallic inks was lower than 2 Ω·□-1, as shown in Fig. S1 (ESI†). 
Afterwards, in order to precisely define the active area of the 
electrodes and the pad connections, dielectric SU-8 was 
printed over the sintered layers. An oxygen plasma treatment 
was applied before the printing of the dielectric in order to 
change the surface energy of the printed layers and to increase 
their hydrophilicity (Fig. 1a(iv)). A DS of 15 µm (1693 dpi) was 
selected to print the dielectric which was then cured using a 
UV lamp for 15 s. A more detailed description of the sensor 
fabrication in the membrane is shown in Fig. S2 (ESI†). Fig. 1b 
shows two images of the membrane with the three printed DO 
sensors, showing the high flexibility of the PTFE membrane 
substrate. An o-ring elastomer was positioned to define the 
cell culture area of 34 x 28.5 mm², and to seal the bioreactor, 
as shown in Fig. 1b (right). 
Finally, two electrochemical steps were required to obtain 
functional sensors. Firstly, the printed silver electrode was 
chlorinated by cyclic voltammetry in 0.1 M HCl, scanning the 
potential from 0 V to 0.2 V versus the Ag/AgCl commercial 
reference electrode at 20 mV·s-1 to obtain a stable pRE. 
Secondly, the gold WE surface was electrochemically activated 
in order to enhance its electron transfer kinetics.50 The 
behavior of the gold electrode in many electrolytes is 
influenced by the character of the gold surface. The aim of this 
activation process was to clean and form a uniform atomic 
structure in the metallic electrode surface by desorbing 
impurities and eliminating any native oxide.51 The best 
activation conditions found were 2 pulses alternating between 
- 2 V and 0 V for 5 s in a PBS electrolyte solution. 
 
Cell culture procedure 
For the biological validation of the sensors within the OOC 
device, primary hepatocytes were isolated from male Wistar 
Han rats (Charles River Laboratories Barcelona, Spain) 
weighing 300-350 g housed at the University of Barcelona (UB) 
animal facilities or from remnant peritumoral tissue obtained 
after partial hepatectomy in humans. Biocompatibility tests 
were performed for the inks by culturing hepatocytes onto a 
membrane with printed patterns of the three different used 
inks. Fig. S4 (ESI†) shows that the cells achieved their 
morphological properties by maintaining their viability, as is 
also the case for membranes without sensors. 
All experiments were approved by the Laboratory Animal 
Care and Use Committee of the University of Barcelona and 
were conducted in accordance with the European Community 
guidelines for the protection of animals used for experimental 
and other scientific purposes (European Economic Community 
(EEC) Directive 86/609). Regarding human tissue, the Ethics 
Committee of the Hospital Clínic de Barcelona approved the 
experimental protocol (HCB/2015/0624) and in all cases 
patients received and agreed informed consent. 
Hepatocytes were isolated as previously described in52. 
Briefly, liver tissue was rinsed and digested with 0.015% 
collagenase A in Hank’s containing 12 mM hepes (pH 7.4) and 
4 mM CaCl2 for 10 min at 37 °C. Disaggregated tissue was 
filtered using a 100 µm nylon strainer, collected in cold Krebs’ 
buffer and centrifuged at 50 g for 5 min. Pellets containing 
hepatocytes were rinsed three times with HBSS. Hepatocytes 
above 80% viability (evaluated by trypan blue exclusion) and 
were cultured in PMMA platforms (previously treated with 
oxygen plasma and collagen type 1 coating) with enriched 
culture media and maintained O/N at 37 °C in a humidified 
atmosphere of 5% CO2. Cells were seeded at a density of 
109.000 cells/cm2. After isolation for 16h, hepatocytes were 
rinsed twice with DPBS and media was changed to DMEMF12 
supplemented with 2.97% dextran to simulate blood viscosity.  
 
Oxygen monitoring experimental procedure 
Prior to embedding the inkjet-printed sensors in the 
membrane, calibration of the sensor platform was performed 
as it is described in the section ‘Experimental procedure’ 
(ESI†). Fig. S3 (ESI†) shows the setup of the experimental 
procedure. 
DO was recorded in real-time and simultaneously every 15 
min in the three points of the bioreactor lower channel where 
the inkjet-printed sensors were placed. A commercial Clark-
type sensor was set to obtain measurements every second at a 
single point on the upper channel. After 3 h of culture 
Fig. 1 a) Fabrication steps of the DO sensor based on IJP with printing of the 
primer layer, printing of the gold and silver elements and printing of the 
passivation layer after thermal sintering and plasma treatment, b) photographs 
of the final DO sensors with the attached silicon o-ring on the porous flexible 
membrane.
stabilization, the increase in oxygen consumption from 
hepatocytes was induced by adding FCCP (0.5 µM steps) to the 
culture reservoir. After the first addition, the system was set 
under anaerobic conditions by closing the medium reservoir to 
avoid oxygenation. Real-time oxygen assessment was 
performed for up to 5 h after drug administration to the cell 
culture. Control experiments without cells were also 
performed. N=3 independent cell isolations and experiments 
were performed for both rat and human hepatocytes. 
Results and discussion 
Strategy of blocking the porous membrane with SU-8 
Thanks to advances in technology, it is now possible to 
integrate sensing elements in ultrathin and porous cell culture 
membrane using IJP techniques. However, conductive inks 
cannot be printed directly onto the porous membrane (Fig. 2a) 
as this would cause short circuits and a non-defined electrode 
area. To electrically isolate the sensors from the microfluidic 
medium, the porosity of the membrane was sealed using a 
primer layer (Fig. 2b). The primer layer was locally printed just 
under the electrodes area blocking the minimal area, in order 
to not affect the diffusion inside the membrane. With this 
strategy, a smooth and non-porous surface of conductive 
materials can be obtained after the printing of the primer layer 
(Fig. 2c). SU-8 was selected because as it is an UV curable ink 
formulation, it forms quite thick layers compared with 
standard solvent-based ink formulations, allows the efficient 
sealing of the porous membrane and due to its 
biocompatibility with cell culture systems.49 Different numbers 
of SU-8 layers were printed and tested (non-primer (0L), one 
(1L), two (2L), three (3L) and four layers (4L)). Fig. 2b(i-iv) 
shows the sealing of a 10 µL volume water drop on top of 
various primer layers. Additionally, Fig. 2b(v-viii) shows the 
cross section of the membrane showing the SU-8 penetration 
for the different number of layers applied. In the case of 1L, 
the water droplet was completely absorbed by the porous 
membrane and did not form a sessile droplet on top (Fig. 
2b(i)). In this case it is very difficult to observe the SU-8 in the 
membrane (Fig. 2b(v)), the SU-8 covered the fibres of the 
membrane without sealing its porosity, just a thin layer of SU-8 
at a penetration depth of about 2.4 ± 1 µm can be identified 
Fig. 2b(ix) shows the measured primer layer thicknesses for 
the different number of layers, taking into account the SU-8 
ink that was penetrated inside the membrane and also the 
material that was overflowing above the membrane. In the 
case of 2L, the porosity of the membrane was already blocked 
and the drop water test remained on the sealed membrane 
surface (Fig. 2b(ii)). The SU-8 had a penetration depth of about 
16.8 µm ± 3 µm as shown in Fig. 2b(vi). In the case of 3L and 4L 
it can be considered that the polymer was completely blocking 
the membrane. In these cases, the SU-8 had already formed a 
thin layer overflowing above the membrane. In the case of 3L, 
the ink penetration depth in the membrane was about 28.5 ± 4 
µm and the layer thickness on top of the membrane about 6.9 
± 3 µm (Fig. 2b(vii)). For the 4L the penetration depth of SU-8 
was about 31.2 ± 5 µm and the SU-8 formed a smooth layer on 
top of the membrane of about 20.7 ± 5 µm (Fig. 2b(viii)). 
 
Printing of the conductive inks onto the primer layer 
The printing behaviour of gold and silver inks on top of the 
primer layer deposited on the porous membrane was studied. 
One layer of the conductive inks was printed in patterns of 4 x 
4 mm² over a SU-8 pattern of 5 x 5 mm² for the different 
number of primer layers, as shown in Fig. S5 (ESI†). With 1L of 
primer, the silver ink penetrated completely inside the 
membrane and no conductivity was achieved. In the other 
cases; 2L, 3L and 4L of silver, a well-defined square could be 
obtained with sheet resistance values below 1 Ω·□-1 after a 
sintering process of 130 °C for 40 min, showing the proper 
sealing function of the primer layer. 
In the case of gold, similar results were obtained and 2 
printed layers (2L) of primer ink were enough to form a 
smooth printed layer with a sheet resistance of < 2 Ω·□-1 after 
a sintering process of 130 °C for 40 min. In order to optimize 
the material waste and time cost, 2 layers were selected for 
developing the primer. Fig. 2c shows a cross-section of a layer 
of silver ink printed onto the selected 2L of primer. 
 
Passivation strategy 
The surface energy of the SU-8 printed layers was 
determined to be about 30.1 mN·m-1 with a highly dispersed 
part of about 25.4 mN·m-1 and a polar part of only 4.7 mN·m-1 
using the Owens, Wendt, Rabel, and Kaelble method.53 This 
surface energy normally has enough wettability for printing 
the conductive inks. However, the small polar part made it 
difficult to print the SU-8 insulator on top of the SU-8 primer 
layer, obtaining splitting droplets, as shown in Fig. S6a (ESI†). 
To improve the wettability of the SU-8 ink, an oxygen plasma 
treatment was performed54 to increase the amount of oxygen 
and carboxyl groups at the surface and, thus increase surface 
energy.55The very gentle plasma conditions to change the 
affinity of the primer and the passivation layers were found as 
24 W during 30 s with an oxygen gas pressure of 0.5 bar. With 
these plasma conditions, a change in the water contact angle 
from 89° to only 32° was achieved which in turn remarkably 
improved the layer formation, as shown in Fig. S6c-d (ESI†). 
The plasma treatment increased the wettability of the 
material, achieving surface energy values of about 37.3 mN·m-1 
with a reduction of the disperse part to about 21.8 mN·m-1 
and a high increase in the polar part from 4.7 mN·m-1 to 15.5 
mN·m-1. 
 
Inkjet-printed sensors integration in the ExoLiver 
The same electrochemical three electrode system described in 
our previous work44 was used for the development of the DO 
sensors. In particular, sensors with a smaller WE diameter (300 
µm) were fabricated and tested in this work since the aim was 
to leave free the maximum area of membrane in order to 
maintain filtration. 
From the point of view of the application, there were two 
requirements: i) to simultaneously monitor the oxygen at 
three points of the cell culture area: at the inflow (periportal-
like), at the middle and at the outflow (perivenous-like), to 
determine if an oxygen gradient along the chamber was 
present, and ii) to minimally modify and easily adapt the 
membrane to the Liver-On-a-Chip bioreactor. 
  Fig. 3a shows a schematic of the OOC system used in this 
work. After the printing of the three electrode structure of the 
DO sensors, an o-ring silicone based elastomeric gasket was 
attached to it, encompassing a cell culture area of 969 mm2 
(34 mm x 28.5 mm). The detailed fabrication of the used 
bioreactor is described in43. Minimal changes were made to 
allow the connection of the sensors, the integration of an 
external Ag/AgCl RE and the commercial Clark-type oxygen 
sensor. These two external elements were incorporated at the 
top plate of the system to support the functionality and 
response of our developed sensors. Fig. 3b shows a cross-
section of the bioreactor with the three printed sensors 
embedded in the porous membrane along the microfluidic 
channel and with the external RE and the Clark-type oxygen 
sensor. The sensors on the membrane were located facing the 
bottom channel, directly facing the seeded hepatocyte cell 
culture where the major oxygen concentration changes were 
expected to be measured. In particular, for the connection of 
the printed sensors to an external potentiostat, individual 
spring load connectors were incorporated in the top plate of 
Fig. 2 a) SEM image of the PTFE porous membrane used to separate the inner compartments of the bioreactor, b) schematic of the strategy to block a porous substrate, using a 
primer layer locally sealing the porosity of the membrane, for the case of use one (1L), two (2L), three (3L) and four layers (4L); in (i-iv) is presented the sealing of a water drop on 
top of different numer of layers and in (v-viii) the cross section of the membrane with the SU-8 penetrated on it, and in ix) isrepresenting the thickness of the primer penetration 
depth inside the membrane and the primer overflowing above the membrane, c) cross-section of a conductive ink printed onto two primer layers. 
the bioreactor. An image of the complete system is shown in 
Fig. 3c, detailing the placement of the sensors. 
 
Sensor characterization and validation 
The sensors were electrochemically characterized in a similar 
way as described in our previous work.44 After the activation, 
electrode behaviour was studied by cyclic voltammetry in 
ferro/ferricyanide (10 mM) solution, as shown in Fig. S7a 
(ESI†). The anodic/cathodic peak current (Ip) values 
determined were Ip= 1.2 ± 0.2 µA which are directly 
proportional to the WE area as described by the Randles-
Sěvčik equation.56 The measurement of oxygen is based on an 
oxygen reduction reaction at the WE, which results in a 
detectable current. As the detection reaction implies oxygen 
consumption, the final interval time for measurement is a 
compromise between obtaining a real-time monitoring and 
not altering the cell culture medium. Oxygen concentration 
was measured with the three inkjet-printed sensors 
simultaneously every 15 min. Each amperometric DO 
measurement took about 60 s. The printed sensors with a 
diameter of 300 µm had an oxygen consumption of about 
2.94·10-8 mgDO·s-1 per sensor in each measurement. This 
consumption was sufficiently low compared with the DO 
consumption caused by the hepatocyte. According to the 
literature, the DO consumption for 106 hepatocytes ranges 
from 0.96 to 2.88·10-5 mgDO·s-1.
57 Therefore, it can be 
considered that the viability of the cell culture remains 
unaltered. On the other hand, the DO consumption caused by 
the commercial Clark-type sensor was very low due to its small 
tip dimensions with about 4.1·10-11 mgDO·s-1. This together 
with its location on the top cover, where the medium was 
freshly maintained by the microfluidics, allowed continuous 
measurement each second. 
The sensors were calibrated by polarization at -650 mV. 
This value was found to be the optimal reduction potential 
value for the determination of the DO concentration without 
interfering with the electro-active compound of the medium. 
The generation of electrons is proportional to the oxygen 
being reduced. Therefore, measurement of the generated 
current could be related to a concentration of oxygen in the 
sample. The linearity and sensibility of the sensors were 
verified in the calibrated medium (PBS) by bubbling a series of 
nitrogen/air gas mixtures. Fig. S7b (ESI†) shows the calibration 
curves. In total, 28 platforms each with three fully-printed DO 
sensors were fabricated and calibrated. The sensors showed 
excellent linearity in the range of 0 to 9 mg·L-1, with a 
sensitivity of 28 ± 1 nA·L·mg-1 and a correlation factor greater 
than 0.99. The limit of detection was 0.11 ± 0.02 mg·L-1. 
DO monitoring inside the ExoLiver 
To assess the functionality of the printed sensors, two types of 
experiments were carried out. In the first, the ExoLiver system 
was assembled without primary cells (acellular ExoLiver) 
allowing the printed sensors to register the supply of oxygen 
to the culture media to serve as a control of the system (Fig. 
4a). In the second type of experiment, the printed DO sensors 
were assembled in the ExoLiver after culturing the bottom 
plate with 1 million fresh primary hepatocytes isolated from 
healthy rats (Fig. 4b) and human (Fig. 4c) livers. We decided to 
perform the proof-of-concept studies in primary cells because 
they have a much higher applicability in the field than 
immortalized cell lines. Fig. 4 shows the measured results with 
a mean of n=3, and details of the DO concentrations in the 
three zones of the bioreactor. Additionally, oxygen was 
continuously measured with the commercial Clark-type sensor 
which was placed in the upper channel at the perivenous zone 
(outflow), due to the difficulty of integrating it in the lower 
channel without interfering with the cells. 
  In all experiments, the first three hours were set as the 
stabilization time required for the microfluidic system. During 
this period, the oxygen supply maintained the viability of the 
 
Fig. 3 Schematic of the OOC system with the modifications to incorporate the control with external elements and the spring load for the connectors on the top plate b) cross-
section of the bioreactor showing the position of the three DO printed sensors, and c) real picture of the ExoLiver system with all the fluidic and electrical connections with the 
three printed sensors along the microfluidic channel and the external RE and Clark-type oxygen elements.
cell culture inside the ExoLiver in both the upper and lower 
plate areas. These procedures ensured the long-term viability 
and functionality of the hepatocyte cell culture. After the 
stabilization period, FCCP (0.5 µM) was added in 3 cumulative 
doses, dispensing a total of 129 µL volume to the culture 
media reservoir to boost hepatocyte respiration. After the first 
addition, the system was set under anaerobic conditions by 
closing the medium reservoir to prevent oxygenation and DO 
concentrations were registered in real-time over the following 
5 hours. FCCP has been described as an uncoupler of oxidative 
phosphorilation by promoting the disruption of the proton 
gradient across the mitochondrial membrane at 
concentrations as low as 1 µM.58 In order to balance the ATP 
supply with the cellular energy requirements, cells increase 
their oxygen-consuming rate to restore the proton gradient 
and overcome the dramatic decrease in intracellular ATP. 
Although this will be further discussed later, in our study the 
response of the hepatocytes for all replicates was observed to 
follow the same biological tendency, corroborating that FCCP 
provoked the increase of oxygen consumption and therefore a 
decrease in the DO concentration of the medium. 
Reproducibility between the three independent 
experiments, shown in Fig. 4 as the grey shaded error bars, 
denotes the maximum deviation between experiments. During 
the whole time of the experiments with rat hepatocytes, DO 
maximum deviation was ± 0.4 mg·L-1 (6%) in the acellular 
ExoLiver, ± 0.8 mg·L-1 (9%) for rat hepatocytes and ± 1.5 mg·L-1 
(17%) for human hepatocytes. These deviations might have 
been caused by 1) the oxygen conditions of the cell culture 
medium; 2) its oxygenation inside the incubator, or 3) 
differences in the seeding time, which could have provoked 
dedifferentiation of the primary hepatocytes thereby causing 
them to lose their liver-specific functions. In the case of the rat 
cells, intra-animal variability is another important factor, since 
primary cells isolated from different animals may differ in their 
metabolic response. In the case of the human cell 
experiments, higher variability can be undoubtedly explained 
due to basal differences in human liver donors. 
As expected for the control experiments (acellular 
ExoLiver, Fig. 4a), the oxygen in the medium remained at 
optimal values without observing any change during the whole 
experiment, thus demonstrating that FCCP had no effect on 
the behaviour of the sensors. A slight decrease of the DO 
concentration could be observed at t= 180 min, corresponding 
to the opening of the incubator door for the FCCP addition; 
however it quickly recovered in the incubator conditions. As 
expected for the absence of cells, measurements of the three 
printed microelectrodes were of approximately the same DO 
concentration and no gradient of oxygen in the zoom image of 
Fig. 4a was observed in the lower plate. In addition, no 
substantial difference was noticed with the Clark-type sensor 
in the upper microfluidic channel. 
 
DO monitoring with rat hepatocyte ExoLiver 
In the rat hepatocyte ExoLiver (Fig. 4b), during the stabilization 
time, the cell media had enough nutrients to maintain both an 
adequate DO level and the viability of the cell culture inside 
the ExoLiver. In order to increase the respiratory activity of 
cells, FCCP was added as previously described and a final DO 
concentration of about 2.4 ± 0.4 mg·L-1 was detected at t=480 
min in the medium. Hepatocyte cellular viability was 
determined by observing polygonal shapes with angular edges. 
Fig. 4d shows human hepatocyte cells, which are similar to the 
results obtained with rat cells. These images demonstrate the 
Fig. 4 DO monitored during 8 hours (green is the sensor placed in the inflow, blue r the middle, red the outflow and black for the commercial DO Clark-type sensor with n=3 
experiments (grey shaded is the bar error between experiments) in three cases, a) control without primary cells (acellular OOC) with a zoon in a section of the of the graph
plotted for better readability of the different DO concentrations as a function of sensor position, b) with primary rat hepatocytes cell culture, and c) with primary human 
hepatocytes, with the addition of the FCCP drug after the 3 hours of stabilization, d) microscopic images of human hepatocytes cell culture at the begging (top) and at the end 
(bottom) of the experiment. 
high viability and unchanged morphology of the hepatocytes 
at the beginning and end of the experiment. The low DO 
concentration values found when the experiment had finished 
prompted us to consider an alternative mechanism by which 
the primary hepatocytes were obtaining ATP and cell death 
was prevented. We proposed that primary hepatocytes could 
be using anaerobic glycolisys in our experimental setting since 
this anaerobic metabolism is independent of oxygen and 
oxidative phosphorilation. Although anaerobic glycolisys is less 
efficient, it might have been sufficient to maintain the basal 
requirements of our cells for the short time they received FCCP 
treatment. Furthermore, this mechanism has been widely 
described as a biochemical feature of some tumor cells, which 
increase their cell energy production in the hypoxic 
microenvironment of the tumour.59,56 
 
Oxygen gradient 
The monitoring of changes in oxygen concentration in real-
time allowed us to determine whether an oxygen gradient 
existed along the hepatocyte cell culture. To this end, different 
oxygen concentrations for rat hepatocyte cells were measured 
along the lower plate bioreactor as detailed in the zoom of Fig. 
4b. Changes of up to 17.5% were measured between the 
inflow and the outflow. This gradient can be explained by the 
consumption of the cells along the lower plate of the 
bioreactor resulting in lower DO values at the outflow area of 
the system. We are confident that the metabolic activity of the 
hepatocytes along the sinusoid was mainly responsible for this 
oxygen gradient due to the fact that throughout the control 
experiment, no significant differences were observed in any of 
the three regions. In healthy liver tissue, the metabolic activity 
of hepatocytes along the sinusoid results in differences of 
about 50% between the periportal and the perivenous zones.53 
The gradient differences found in our study between reality 
and the design underline the importance of oxygen monitoring 
for assessing an OOC device. This is particularly the case with 
liver tissue in which the oxygen gradient plays a strong 
regulatory role and is directly related to metabolic zonation, 
which is crucial for detoxifying xenobiotic metabolism. 
 
DO monitoring with human hepatocytes ExoLiver 
The same experimental approach was performed with primary 
human hepatocytes (Fig. 4c), which confirmed the results from 
rat hepatocytes. In this case, a higher oxygen gradient was 
observed of up to 32.5% between the inflow and the outflow. 
This gradient demonstrates that the reproducibility of the 
sinusoidal milieu of a human liver using primary human 
hepatocytes53 is more realistic than the obtained gradient with 
rat hepatocytes of a rat liver. Because zonation directly affects 
macronutrient metabolism, morphology and xenobiotic 
transformation in hepatocytes, the oxygen gradient found in 
our device could indeed have contributed to a better 
reproduction of the sinusoidal milieu and therefore to the 
maintenance of the hepatocytes.39 This is especially relevant 
both to properly reproduce hepatic microcirculatory 
characteristics (and therefore to mimic nature as much as 
possible), but also to allow the analysis of sub-populations of 
hepatic cells that have been cultured in vitro in a sinusoidal 
milieu under different concentrations of oxygen. 
 
Bioreactor system modelling for OCR estimation 
Oxygen consumption varies widely in different cell types and 
various methods of measuring the rate of oxygen consumption 
(OCR) are still a challenge in OOC systems, where dynamic and 
static fluidic conditions are combined in the bioreactor. 
For the OCR analysis in our study, we proposed a one 
phase model developed to describe the complex ExoLiver 
reactor dynamics, which took into account the microfluidic and 
static channel separated by a membrane. It considered mineral 
solution recirculation through the upper channel and static 
flow within the bottom channel. The model included the 
mathematical expressions for the description of mass 
transport by adventive flow in the upper channel, mass 
transport through the upper and lower channel and diffusive 
mass transport within the lower channel. The theoretical 
model describing DO distribution was based on the mass 
balance along the ExoLiver reactor. Development of the 
mathematical model was based on the assumptions underlying 
consolidate models,61 as follows: 
- Liquid phase recirculation regime in the axial direction 
was modelled considering plug flow. There was no radial 
velocity or axial dispersion. 
- High permeable membrane and no mass transport 
resistance between upper and lower channel was 
considered. 
- Liquid phase static flow was considered within the lower 
channel. 
- Diffusive mass transport within lower channel was 
described following Fick’s law. 
- OCR is described using Michaelis-Menten kinetics.62 
- Different maximum OCR’s (Vmax) were considered at 
different times related to the addition of FCCP and along 
the bottom channel. 
 Mass balance in the upper channel was expressed following 
Eq. (1), 
డ஽ை
డ௧
= 𝑣௅ ·
డ஽ை
డ௫
− 𝐷௠ ·
డ ஽ைమ
డ௭మ
,                       (1) 
where DO is the dissolved oxygen concentration in the upper 
channel (mol·m-3), t is time (s), vL is the axial liquid velocity(m·s
-
1), x is the axial direction (m), Dm is oxygen molecular diffusion 
coefficient (m2·s-1) and z is the radial direction (m). 
Mass balance in the down channel is shown in the 
following equation: 
డ஽ை
డ௧
= 𝐷௠ ·
డ ஽ைమ
డ௭మ
− 𝑉௠௔௫ ·
஽ை
௄೘ା஽ை
 ,               (2) 
where Vmax is the maximum OCR in the lower channel (mol·m
-
3·s-1) and Km is the affinity constant for DO (mol·m
-3). The 
resolution of the balance equations (Eq. (1) and Eq. (2)) that 
describe oxygen distribution along the ExoLiver reactor was 
done by a discretization procedure. The goal of the 
discretization was to simplify partial differential equations 
(depending on time (t), axial direction (x) and radial direction 
(z)) to ordinary differential equations (only depending on time 
(t)). With this aim, plug flow was divided into 3 sections, 
described as stirred tank reactors (with homogeneous 
properties). This division was carried out both in the upper and 
the lower channel. The results of the discretization are 
presented in Fig. 5a. The resulting set of ordinary equations 
was solved using MATLAB in a homemade modelling 
environment. A variable order method was used for solving 
stiff differential equations based on numerical differentiation 
formulas (NDFs). Selected model parameters were estimated 
during the calibration step by fitting the experimental DO 
concentrations to model predictions to describe the dynamics 
of the ExoLiver reactor. The fitting method was based on 
seeking the minimum value of the objective function (Eq. (3)). 
This function was defined as the norm of the differences 
between the predicted DO concentrations by the 
mathematical model and the experimental data: 
             𝐹 = ට∑ ൣ𝑦௘௫௣,௜ − 𝑦ఏ,௜൧௡௜ୀଵ  ,                          (3) 
where F is the objective function to minimize, n is the number 
of experimental measurements, yθ,i is the simulated DO 
concentration (mol·m-3) and yexp,i is the experimentally 
measured dissolved oxygen concentration (mol·m-3). 
Qualitatively simulated profiles reproduced the experimental 
trend of DO along the lower channel throughout the 
monitoring (Fig. S8, ESI†). The quantitative comparison 
between the simulating the ExoLiver performance and the 
experimental DO profiles (obtained with microelectrodes) at 
the inflow, the middle and the outflow of the lower channel 
for rat and human cells monitoring is presented in Table S1 
(ESI†). 
Fig. 5b shows the individual OCR values along the bottom 
channel estimated using the model previously described for rat 
and human cells. As basal respiration, OCR of hepatocyte 
monocult
ures 
calculated 
from the 
stabilizati
on time 
were 0.23 
± 0.07 
nmol/s/10
6 cells for 
rat cells 
and 0.17 ± 
0.10 
nmol/s/10
6cells for 
human 
cells, 
which are 
in good 
agreemen
t with 
previously 
published 
data.63,64 
As 
expected, 
the 
presence 
of FCCP uncouples the mitochondria and increases oxygen 
consumption from the first dose of the drug by 10 times for rat 
cells and just 5 times for human cells. The sequential injection 
of FCCP affected the rat and human hepatocytes in different 
ways. For rat cells, each additional dose increased the OCR by 
1.6 ± 0.2 times with respect the the previous dose, resulting in 
a mean OCR value of 2.33 ± 0.28 nmol/s/106cells after the first 
dose, 3.45 ± 0.76 nmol/s/106cells after the second dose and 
5.95 ± 0.67 nmol/s/106cells after the third dose. However, for 
human hepatocytes, the higher effect was observed after the 
second dose of the drug, with an increase of up to 10.62 ± 1.15 
nmol/s/106cells, and after the third dose, OCR recovered to a 
value of 3.98 ± 0.29 nmol/s/106cells. It can be observed that 
human cells were better able to support depolarization of the 
mitochondrial membrane potential after the first dose; 
however, once it was disrupted, the second dose caused a high 
level of oxygen depletion. The differential respiration 
behaviour observed for human cells after the first dose may 
also be explained as a result of the small interval time between 
the first and second dose: the interval induced an 
accumulative drug effect, and after the third dose, normal 
behaviour was restored. 
Also, changes in the individual OCR values along the inflow, 
the middle and the outflow were observed. For both cell types, 
and for all FCCP additions, cell respiration was increased along 
the bottom channel. Cells seeded at the outflow zone 
presented a higher oxygen consumption with a mean increase 
of about 1.2 ± 0.1 times between the inflow and the outflow 
for rat cells, and 1.4 ± 0.2 times for human cells, respectively. 
As the oxygen gradient is depleted along the channel by 
oxygen cell respiration, cells of the inlet sector maintain a 
more aerobic metabolism, while cells of the middle and the 
outflow have already become used to having less oxygen and 
are more dependent on an anaerobic cell glycolysis. 
 In general, for all the experiments performed, the 
commercial Clark-type sensor data was in good agreement 
with the measurements of the printed sensors, thus validating 
the experiment. However, as can be seen in Fig. 4b and c, a 
major advantage of our system is that it was able to measure 
the DO gradient, whereas the commercial sensor could not. 
This was due to the fact that measurement of the DO gradient 
requires an array of sensors in the lower channel where the 
oxygen changes occur in the immediate vicinity of the cell 
culture. 65 In contrast, the commercial sensor was only able to 
take a single measurement at its location in the outflow of 
upper channel and could not measure oxygen consumption at 
the same time as changes occurred. Admittedly, this problem 
could be solved by inserting several sensors, notwithstanding 
the technological difficulties that this would imply and an 
increase in the final cost of the whole system. The fact that our 
DO printed sensors situated in the lower plate were able to 
detect changes before the commercial sensor situated in the 
upper plate emphasizes the physical limitations of commercial 
sensors and the high potential of inkjet-printed sensors 
located on the membrane of a bioreactor. In addition, the size 
and shape of DO printed sensors can be easily configured for 
integration in any membrane, top or lower channel of any OOC 
system. 
Fig. 5 a) The bioreactor modelling describing DO distribution based on the mass 
balance along the microfluidic and static channels separated by a membrane and 
divided in the three studied zones (inflow, middle and outflow). b) OCR 
estimation in the inflow, middle and outflow of the bioreactor bottom channel 
for the stabilization period and after the three FCCP additions for rat and human 
hepatocyte cells. 
Conclusions 
We presented a novel approach for integrating sensors in 
an OOC system using IJP technology to allow in-situ 
measurements in real-time. Particularly advantageous was the 
possibility of integrating an array of DO sensors directly on a 
thin, flexible, delicate and porous cell culture membrane, 
which was used as a printing substrate. The strategy of locally 
sealing the porosity of the membrane using a biocompatible 
dielectric ink was studied, detailed and successfully applied on 
the membrane. The printed DO sensors were integrated in 
different locations of a previously described Liver-On-a-Chip 
system, exhibiting very good performance, with a linear 
response in a wide range of oxygen concentrations and with a 
low limit of detection. Its response was verified with a 
standard, commercially available Clark-type DO sensor. The 
functionality of our DO sensors was successfully demonstrated 
with primary rat and human hepatocyte cells cultivated in the 
lower plate. The location of the sensors at the inflow, middle 
and outflow zones of the bioreactor, allowed the 
measurement of an oxygen gradient up to 17.5% for rat cells 
and 32.5% for human cells. As the gradient of oxygen 
concentration is a phenomenon that is observed in almost all 
cell types and not only in hepatocytes and even in organs 
themselves, the results here obtained show that sensor 
responses are reliable for real-time monitoring of 
mitochondrial respiration at different areas of cell culture, 
paving the way for the use of this approach in any other OOC. 
The addition of several doses of FCCP provoked an increase in 
oxygen consumption up to 5.95 ± 0.67 nmol/s/106cells with 
respect to the control period for the experiment with rat cells 
and up to 10.62 ± 1.15 nmol/s/106cellsfor human cells. For rat 
hepatocytes it could be determined that OCR values at the 
outflow zone were 1.2 ± 0.1 times higher than in the inflow 
and 1.4 ± 0.2 times for human cells. Here it has been possible 
to demonstrate that cells at the inlet of the bioreactor 
maintain a more aerobic metabolism, while cells of the middle 
and the outflow have already become used to having less 
oxygen and are more dependent on an anaerobic cell 
glycolysis. 
In summary, the results obtained in this work demonstrate 
that IJP is a feasible technique to integrated electrochemical 
sensors inside an OOC device for the online monitoring with 
minimal invasion, as they have a small footprint that can be 
arranged in arrays due to their low thickness and customizable 
size and shape. In addition, they allow a flexible, simple and 
seamless integration in different parts of the system, 
overcoming the higher cost and technological effort to include 
sensors inside OOC devices. The upgrade of OOC devices with 
printed sensors may open new research avenues where cells 
will be properly cultured and physiological measurements of 
different metabolic parameters, such as oxygen, pH, glucose 
and lactate15,38 will be performed in real-time and close to the 
cells to obtain pericellular readings.  
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